Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice
What this study shows
Deleting one or both copies of Tsc1 only in cerebellar Purkinje cells raised phospho-S6 (a readout of mTORC1) in those cells. Both heterozygous and homozygous mutants showed autism-like behaviour: no preference for a mouse over an object or for a new mouse, more self-grooming, more pup ultrasonic calls and poorer reversal learning in a water T-maze. Purkinje cells fired fewer action potentials, both spontaneously and when driven, in a gene-dose-dependent way, while their synaptic inputs looked largely normal; homozygous mutants also lost Purkinje cells from about 2 months of age and became ataxic. Rapamycin (6 mg/kg intraperitoneally, three times a week from postnatal day 7) prevented the Purkinje cell loss and enlargement and the social, learning and motor deficits. Boundary: mouse, cell-type-specific genetic deletion; rapamycin given from early postnatal life, so this is prevention, not reversal; relevance to human autism is by analogy with TSC patients.
At a glance
| Evidence type | A Animal model Marked A because it is an animal intervention or observation study measuring an organismal outcome (model: L7Cre;Tsc1 flox mice (Purkinje-cell-specific heterozygous and homozygous Tsc1 deletion); cerebellar slice electrophysiology; behaviour; rapamycin from P7); the code names the system studied -- animal work can be rigorous and still not be human data. |
| Study type | 4 - Animal Study |
| Model system | L7Cre;Tsc1 flox mice (Purkinje-cell-specific heterozygous and homozygous Tsc1 deletion); cerebellar slice electrophysiology; behaviour; rapamycin from P7 |
| Journal | Nature |
| Year | 2012 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1038/nature11310 · PMID 22763451 · Free full text (PMC3615424) |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Purkinje-cell-specific Tsc1 deletion; rapamycin |
| Target | TSC1/TSC2 -> mTORC1 |
| Model | Mouse |
| Effect | Tsc1 loss in Purkinje cells caused autism-like behaviour and reduced PC excitability; rapamycin prevented the deficits |
In the Atlas
Related topics
Links in the pathway map
- Supports TSC1/TSC2 inhibits mTORC1
More studies on this topic
- Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis (2013)
- Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis (2008)
- A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells (2002)
- mTORC1 drives cell-autonomous astrocyte reactivity in tuberous sclerosis (2026)
Thank you. Your answer was counted anonymously.